THC Increased Anxiety and Brain Fear Responses While CBD Reduced Them
THC and CBD had opposite effects on brain responses to fearful faces: THC increased anxiety and skin conductance responses while CBD reduced amygdala activation and autonomic arousal.
Quick Facts
What This Study Found
Fifteen healthy men received THC (10 mg), CBD (600 mg), or placebo before viewing faces expressing different levels of fear during fMRI scanning.
THC increased anxiety, intoxication, sedation, and psychotic symptoms. CBD showed a trend toward reducing anxiety.
The drugs had clearly opposite effects on physiological responses to intensely fearful faces. THC increased skin conductance fluctuations while CBD decreased them.
CBD specifically attenuated activation in the amygdala (a key fear-processing region) and the anterior and posterior cingulate cortex. The suppression of amygdala and anterior cingulate responses correlated with the concurrent reduction in skin conductance.
THC mainly affected frontal and parietal brain areas rather than the limbic system.
Key Numbers
15 participants. THC: 10 mg oral. CBD: 600 mg oral. CBD reduced amygdala, anterior cingulate, and posterior cingulate activation. Amygdala suppression correlated with reduced skin conductance.
How They Did This
Double-blind, randomized, placebo-controlled crossover study. Fifteen healthy men with minimal cannabis experience completed three fMRI sessions, receiving THC (10 mg oral), CBD (600 mg oral), or placebo. They viewed faces expressing varying levels of fear while brain activation and skin conductance were measured.
Why This Research Matters
This study provided a neural explanation for why THC can increase anxiety while CBD may reduce it. The finding that CBD calms the amygdala (the brain region most associated with fear processing) offered a biological basis for CBD anxiety research.
The Bigger Picture
This study from the same research group as RTHC-00346 further demonstrated that THC and CBD have fundamentally different and sometimes opposing brain effects. These findings helped build the scientific foundation for subsequent CBD anxiety research.
What This Study Doesn't Tell Us
Only 15 male participants with minimal cannabis experience. Single acute doses may not reflect chronic use effects. The emotional processing task (viewing faces) is artificial compared to real-world anxiety triggers.
Questions This Raises
- ?Would CBD reduce anxiety-related brain activation in people with clinical anxiety disorders?
- ?Could CBD counteract THC-induced anxiety when taken together?
- ?Do these effects persist with repeated use?
Trust & Context
- Key Stat:
- CBD reduced amygdala activation to fearful faces, correlating with reduced autonomic arousal
- Evidence Grade:
- Well-designed crossover RCT but very small sample (n=15) of only healthy men with minimal cannabis exposure.
- Study Age:
- Published in 2009. These findings have been influential in the subsequent CBD-for-anxiety research field, with larger studies generally supporting the anxiolytic effects of CBD.
- Original Title:
- Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
- Published In:
- Archives of general psychiatry, 66(1), 95-105 (2009)
- Authors:
- Fusar-Poli, Paolo(12), Crippa, José A(12), Bhattacharyya, Sagnik(39), Borgwardt, Stefan J, Allen, Paul, Martin-Santos, Rocio, Seal, Marc, Surguladze, Simon A, O'Carrol, Colin, Atakan, Zerrin, Zuardi, Antonio W, McGuire, Philip K
- Database ID:
- RTHC-00353
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does CBD actually reduce anxiety?
This study found CBD reduced amygdala response to fearful stimuli and showed a trend toward lower anxiety ratings. However, the sample was small and the participants were healthy, not anxious. Clinical anxiety trials have since provided more direct evidence.
Why do THC and CBD have opposite effects on anxiety?
They act on different brain regions and through different mechanisms. CBD dampened limbic system (emotional) responses while THC mainly affected frontal and parietal (cognitive) regions, contributing to different subjective experiences.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- why-does-weed-make-you-paranoid-amygdala
- why-weed-makes-me-anxious-now-not-before
- thc-and-benzodiazepines-dangerous-overlap
- cannabis-and-socializing-only-use-around-others
Cite This Study
https://rethinkthc.com/research/RTHC-00353APA
Fusar-Poli, Paolo; Crippa, José A; Bhattacharyya, Sagnik; Borgwardt, Stefan J; Allen, Paul; Martin-Santos, Rocio; Seal, Marc; Surguladze, Simon A; O'Carrol, Colin; Atakan, Zerrin; Zuardi, Antonio W; McGuire, Philip K. (2009). Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.. Archives of general psychiatry, 66(1), 95-105. https://doi.org/10.1001/archgenpsychiatry.2008.519
MLA
Fusar-Poli, Paolo, et al. "Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.." Archives of general psychiatry, 2009. https://doi.org/10.1001/archgenpsychiatry.2008.519
RethinkTHC
RethinkTHC Research Database. "Distinct effects of {delta}9-tetrahydrocannabinol and cannab..." RTHC-00353. Retrieved from https://rethinkthc.com/research/fusar-poli-2009-distinct-effects-of-delta9tetrahydrocannabinol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.